Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04611620 · ClinicalTrials.gov registry record
Biobehavioral Correlates of Cancer-related Cognitive Dysfunction and Its Co-occurring Symptoms
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 682
- Enrollment target
NCT04611620: Completed study, sponsored by Indiana University.
NCT04611620 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 682 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04611620 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 682 participants
- Enrollment target
Study Summary
This descriptive, cross-sectional study will evaulate and fully characterize factors associated with cognitive dysfunction in Breast Cancer (BCS) and Colorectal Cancer (CRC) survivors that have cognitive concerns, and factors associated with psychoneurological symptom cluster in BCS and CRC survivors.
Primary Outcome
PROMIS - Cognitive Abilities and Concerns
Interventions
- BEHAVIORAL Cognitive Dysfunction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 682 participants |
| Start Date | 2020-11-16 |
| Est. Completion | 2021-07-27 |
What the finished NCT04611620 record still lists
NCT04611620 is an observational study that tracks outcomes without assigning an intervention. The registered 682 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Cognitive Dysfunction is the first listed.
NCT04611620 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04611620 about?
NCT04611620 is a clinical study titled "Biobehavioral Correlates of Cancer-related Cognitive Dysfunction and Its Co-occurring Symptoms". This descriptive, cross-sectional study will evaulate and fully characterize factors associated with cognitive dysfunction in Breast Cancer (BCS) and Colorectal Cancer (CRC) survivors that have cognitive concerns, and factors associated with psychoneurological symptom cluster in BCS and CRC survivor...
What is the current status of trial NCT04611620?
This trial is currently completed. The enrollment target is 682 participants. The study started on 2020-11-16. Estimated completion is 2021-07-27.
What interventions are being tested in trial NCT04611620?
The interventions under investigation include: Cognitive Dysfunction (BEHAVIORAL).
Who is sponsoring clinical trial NCT04611620?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05382559 · 681 participants · Phase 1
A Study of ASP3082 in Adults With Advanced Solid Tumors
- NCT06795087 · 684 participants
Discharge Medication Use Post-Operatively in GU Cancer Patients
- NCT03501706 · 680 participants · NA
An Assessment of Cognitive Improvement Training Among Mid-life Individuals
- NCT05626452 · 680 participants · NA
PrEP Optimization Among Women to Enhance Retention and Uptake
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI